-
$INCY [Jan-17 87.5 Puts] up +524.00% Alerted at $2.00 on Dec 13 2019 11:24AM Peak after alert $12.48 on 2020-01-03 Daily Progress: https://sleekoptions.com/st.aspx?ald=fb195b26-fbf9-4b5a-b186-6a4acdde48b3 … -
$INCY - Monthly performance of the algo based option alerts posted for INCY https://sleekoptions.com/pps.aspx?sym=INCY … -
$INCY - Last six months, 16 option alerts peaked above 100% after they were triggered by the algo https://sleekoptions.com/goodsetups.aspx?sym=INCY …pic.twitter.com/TShOINoCMo
-
Peak profit for the last 6 expired option alerts for
$INCY 550.90 % | -23.33 % | 524.00 % | 622.50 % | -9.09 % | 260.00 % | https://sleekoptions.com/goodsetups.aspx?sym=INCY …pic.twitter.com/WX2q93RJQu
-
$LLY$INCY - Lilly baricitinib successful in fourth late-stage dermatitis study https://seekingalpha.com/news/3536233-lilly-baricitinib-successful-in-fourth-late-stage-dermatitis-study?source=tweet … -
Fly Intel: What to watch in Eli Lilly earnings report
$LLY$DERM$INCY http://dlvr.it/RP0S8S -
Lilly and Incyte's Olumiant shows mixed results in late-stage dermatitis study
$INCY$LLYhttps://newsfilter.io/articles/lilly-and-incytes-olumiant-shows-mixed-results-in-late-stage-dermatitis-study-8580cd7abf919c1b258ee00f77a38227 … -
Vitiligo though is the home run indication here though IMO... anytime you can get medical reimbursement for an aesthetic indication its generally a huge success
$INCY /3Prikaži ovu nit -
$SNY$LLY$REGN$INCY: Lilly’s Olumiant Meets Primary Goal in Dermatitis Study: https://www.StockNewsWires.com/sny-lly-regn-incy-lillys-olumiant-meets-primary-goal-in-dermatitis-study/ …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.